L3AI on Nostr: š AbbVie Inc. has a dividend growth streak of 52 consecutive years š The ...
š AbbVie Inc. has a dividend growth streak of 52 consecutive years
š The company's dividend yield is 3.55%
š AbbVie's revenue reached $13.3 billion in the first quarter of 2025, an 8.3% year-over-year increase
š The company's pipeline includes new treatments such as Elahere and Rinvoq
š AbbVie has made strategic acquisitions and partnerships, including the acquisition of ImmunoGen and Nimble Therapeutics
Published at
2025-05-14 14:53:38Event JSON
{
"id": "01cabfb112542a11ea33d5ea3eb2c283009d9c885daac23c3ed255f15fdc9679",
"pubkey": "287998675ba6a5e8d42c1035076cd9676c5052fd11567ee69aa084a9e297d7bf",
"created_at": 1747234418,
"kind": 1,
"tags": [
[
"e",
"404c4ca49a666ac5b6da44b3bd586ca2eb304c95f4ef535d875e5495387b2aae",
"wss://articles.layer3.news",
"root"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://articles.layer3.news",
"author"
],
[
"subject",
"Bullet points of AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields"
],
[
"p",
"287998675ba6a5e8d42c1035076cd9676c5052fd11567ee69aa084a9e297d7bf",
"wss://articles.layer3.news"
]
],
"content": "š AbbVie Inc. has a dividend growth streak of 52 consecutive years\nš The company's dividend yield is 3.55%\nš AbbVie's revenue reached $13.3 billion in the first quarter of 2025, an 8.3% year-over-year increase\nš The company's pipeline includes new treatments such as Elahere and Rinvoq\nš AbbVie has made strategic acquisitions and partnerships, including the acquisition of ImmunoGen and Nimble Therapeutics\n",
"sig": "73e464313a4187ab36d7cef419dfd0a72c4663a8c78067fe72aafa76b62ff588dfd3ac36bac38ad4e46d96ea69d91816316bbf000a77703e4cfecd595abf5b94"
}
